Top of this page
Skip navigation, go straight to the content Newsroom UCB U.S. News


  • UCB Hosts Patients to Share the Art of Advocacy

    Posted by Becky Malone, Engagement and Communications Specialist
    In September, our Raleigh-Durham office hosted their first Art of Advocacy event, which explored how art can be used as a platform for advocacy. The event showcased three artists, from across the U.S., living with a chronic illness, who use art as a medium to cope, spread awareness, and encourage others. We invite you to meet them and learn more about their stories below.

    Read more

  • Like
  • UCB-UNC-Duke Neurology Clinical Development Program

    Posted by Katelyn Snider, U.S. Communications and Public Affairs

    (Left to Right) Dr. Michael Markowitz (UCB), Dr. Shruti Raja, and Dr. Robert Dupuis (UNC Eshelman School of Pharmacy)

    An important part of the drug development continuum is ensuring trained specialists are engaged through discovery, development, and delivery. Neurotherapeutics, or treatment of disorders of the nervous system, is a research area with a limited number of highly trained neurologists working in drug development. To help fill this gap, the UCB-UNC-Duke Neurology Clinical Development Fellowship program was developed for board certified neurologists seeking further training in neurology drug development.

    Read more

  • Like
  • Approach to big data and machine learning presented at AES

    Posted by Allyson Funk, Head of U.S. Communications and Public Relations
    This weekend at the 2018 American Epilepsy Society Meeting (AES) in New Orleans, Louisiana we are highlighting UCB’s commitment to delivering patient value through innovative solutions designed to help ensure the right treatments and care reach patients living with severe diseases.

    Read more

  • Like
  • Starting From a Patient Perspective Focuses Epilepsy Treatment Progress

    As UCB attends the 2018 American Epilepsy Society meeting in New Orleans, Louisiana this week, Mike Davis, Head of UCB’s U.S. Neurology Patient Value Unit, talks about the importance of using innovative approaches to shorten the time it takes a patient to get control of their condition. The following is an excerpt from his LinkedIn article, “Starting from a Patient Perspective Focuses Epilepsy Treatment Progress.” Read the full article on LinkedIn.

    Read more

  • Like